Literature DB >> 11900045

Advantages of new technology pulse oximetry with adults in extremis.

Charles G Durbin1, Stephanie K Rostow.   

Abstract

Thirteen critically ill patients in the thoracic and cardiovascular ICU in whom conventional pulse oximetry (CPO) failed were identified and prospectively studied using an oximeter employing Masimo SET technology (MSO). These patients were elderly and ill, having undergone a variety of thoracic and cardiovascular operations. They were often hypothermic and shivering. Several had arterial assist devices, intraaortic balloon pumps or impending or actual cardiac arrest. In 12 of these patients the MSO was able to determine the actual arterial saturation as calculated from a coincident arterial blood gas. In the one patient, in whom no saturation was obtained with the MSO, no arterial blood could be obtained due to complete cardiac collapse. This case series demonstrates the value of the new Masimo SET technology for pulse oximetry in the most critically ill and demanding clinical situations in which other techniques have failed. A significant improvement in patient safety resulted from use of this improved oximetry.

Entities:  

Mesh:

Year:  2002        PMID: 11900045

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

1.  Oximetry-guided reoxygenation improves neurological outcome after experimental cardiac arrest.

Authors:  Irina S Balan; Gary Fiskum; Julie Hazelton; Cynthia Cotto-Cumba; Robert E Rosenthal
Journal:  Stroke       Date:  2006-10-26       Impact factor: 7.914

2.  The incidence of hypoxemia during surgery: evidence from two institutions.

Authors:  Jesse M Ehrenfeld; Luke M Funk; Johan Van Schalkwyk; Alan F Merry; Warren S Sandberg; Atul Gawande
Journal:  Can J Anaesth       Date:  2010-07-31       Impact factor: 5.063

3.  Prevention of retinopathy of prematurity in preterm infants through changes in clinical practice and SpO₂technology.

Authors:  Armando Castillo; Richard Deulofeut; Ann Critz; Augusto Sola
Journal:  Acta Paediatr       Date:  2010-10-15       Impact factor: 2.299

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.